Conclusions
Idiopathic detrusor overactivity is often very distressing for patients, because they cannot predict when they will leak. It is also rather frustrating for the clinician, because we do not yet understand the cause of the condition, and we have no “cure”. Patients need to be treated as sympathetically as possible, with meticulous bladder training, and attempts to find the best therapy for each woman. It is also important to emphasize that a great deal of research is ongoing, to discover the cause and find better treatments.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amarenco G, Ismael SS, Even-Scneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, Derdraon J (2003) Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 169:2210–2215.
Awad SA, AlSahrani HM, Gajewski JB, Bourque-Kehoe AA (1998) Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 81:569–573.
Benness C (1992) Vaginal oestradiol for postmenopausal urinary symptoms, a double blind placebo controlled study. Proceedings of FIGO, Stockholm.
Bosch J, Groen J (1995) Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: Results of chronic electrical stimulation using an implantable neural prosthesis. J Urol 154:504–509.
Bower WF, Moore KH, Adams R (1998) A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. J Urol 106:2133–2136.
Brubaker L, Benson JT, Bent A, Clark A, Shott S (1997) Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol 177:536–540.
Burton G (1994) A randomised cross over trial comparing oxybutnin taken three times a day or taken “when needed”. Neurourol Urodyn 13:351–352.
Chang PL (1988) Urodynamic studies in acupuncture for women with frequency, urgency and dysuria. J Urol 140:563–566.
Cruz F (2002) Vanilloid receptor and detrusor instability. Urology 59(Suppl 5A):51–60.
Delaere KP, Debruyne FM, Michiels H, Moonen W (1980) Prolonged bladder distension in the management of the unstable bladder. J Urol 124:334–336.
Freeman RM (1987) A psychological approach to detrusor instability incontinence in women. Stress Med 3:9–14.
Goldberg RP, Galloway NT, Sand PK (2004) Extracorporeal electromagnetic stimulation therapy. In: Bourcier AP, McGuire EJ, Abrams P (eds) Pelvic floor disorders. Elsevier Saunders, Philadelphia, Chapter 30, pp 291–296.
Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P (2001) Cutaneous afferent neuromodulation for the refractory overactive bladder: Results of a multicenter study. J Urol 165:1193–1198.
Hasan ST, Robson WA, Pridie AK, Neal DE (1994) Outcome of transcutaneous electrical stimulation in patients with detrusor instability. Neurourol Urodyn 13:349–350.
Hassouna MM (2003) Sacral nerves neurostimulation. In: Drutz HP, Herschorn S, Diamant NE (eds) Female pelvic medicine and reconstructive pelvic surgery. Springer, London, Chapter 27, pp 299–312.
Herbison P, Hay-Smith J, Ellis G, Moore KH (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: Systematic review. Br Med J 326:841–847.
Kumar V, Cross R, Chess-William R, Chapple C (2005) Recent advances in basic science for overactive bladder. Curr opin Urol 15:222–226.
Leng WW, Blalock HJ, Fredriksson WH, English SF, McGuire EJ (1999) Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol 161:758–763.
Moore KH, Gilpin SA, Dixon JS, Richmond DH, Sutherst JR (1992) An increase of presumptive sensory nerves of the urinary bladder in idiopathic detrusor instability. Br J Urol 70:370–372.
Morris A, O’Sullivan R, Donkley P, Moore KH (2005) Extracorporeal magnetic stimulation in female detrusor overactivity simultaneous cystometry testing and a randomizedsham controlled trial. Neurorol and Urodyn (in press).
Morris AR, Westbrook JI, Moore KH (2003) Idiopathic detrusor overactivity in women-A 5-10 year longitudinal study of outcomes. Neurourol Urodyn 22:460–462.
Philp T, Shah PJR, Worth PHL (1988) Acupuncture in the treatment of bladder instability. Br J Urol 61:490–493.
Ramsden PS, Smith M, Dunn M, Ardran GM (1976) Distention therapy for the unstable bladder: Later results including an assessment of repeat distensions. Br J Urol 48:623–629.
Sahai A, Khan M, Fowler CJ, Dasgupta P (2005) Botulinum toxin for the treatment of lower urinary tract symptoms: A review. Neurourol Urodyn 24:2–12.
Scheepens WA, Van Koeveringe GA, DeBie RA, Weil EH, Van Kerrebroeck PE (2002) Long term efficacy and safety results of the two stage implantation techniques in sacral neuromodulation. Br J Urol Int 90:840–845.
Shaker HS, Hassouna MM (1998) Sacral nerve root neuromodulation: Effective treatment for refractory urge incontinence. J Urol 159:1516–1519.
Smet P, Moore KH, Jonavicius J (1997) Distribution and colocalisation of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 77:37–49.
Swami KS, Feneley RC, Hammonds JC, Abrams P (1998) Detrusor myectomy for detrusor overactivity: A minimum 1 year followup. Br J Urol 81:68–72.
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
(2006). Step-by-Step Guide to Treatment of Overactive Bladder (OAB)/Detrusor Overactivity. In: Urogynecology: Evidence-Based Clinical Practice. Springer, London. https://doi.org/10.1007/1-84628-165-2_7
Download citation
DOI: https://doi.org/10.1007/1-84628-165-2_7
Publisher Name: Springer, London
Print ISBN: 978-1-84628-164-8
Online ISBN: 978-1-84628-165-5
eBook Packages: MedicineMedicine (R0)